Choose another division
Electrical semiconductor characterization
Luminescence dating, research, dosimetry and more
Free radical measurements in life science and biomedical applications
Our benchtop MiniScope (MS 5000) ESR spectrometer is a research grade device with sensitivity and reliability for demanding...
Industry standard for evaluating irradiation doses on alanine tablets
Nitric oxide measurement, reactive oxygen species, oxidative stress, radical generating systems, photo dynamic therapy
Analysis of chemical structure of paramagnetic centers and their orientation within a crystal
Bioinorganic transition metal compounds, fenton chemistry, effect of heavy metal ions on livving tissue
Variety of free radicals in environmental applications can be evaluated by EPR spectroscopy
Living polymers, nitroxide quantification, radicals in varnish, UV stability of scratch resistant varnish
ESRStudio is a dynamic and user friendly software for ESR measurements with some of the most modern and fluent workflow based...
Magnettech GmbH was founded in 1991 by the members of the department of "Centre for Construction of Scientific Devices"...
For Sales, Technical Support, Service and other General Enquiries
The level of ROS is a key indicator for illness. By monitoring these species, ESR spectroscopy enables new methods of treating diseases like cancer or diabetes.
Nadine Moeller, Jochen Springer, Anika Tschirner, Kai Hartman, Sandra Palus, Eva K. Wirth, Silvia Busquets Ruis, Stephan von Haehling, Josep M. Argiles, Josef Koehrle, Volker Adams, Stefan D. Anker and Wolfram Doehner (2012) Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia. International Journal of Cancer 131, 2187-2196
In modern medicine, cancer treatment faces major obstacles besides the tumor itself. Many cancer patients suffer from cachexia, a constant state of significant weightloss and weakness. An elevated level of uric acid (UA) leads to higher production rates of reactive oyxgen species (ROS) depending on xanthine oxidase (XO) activity. Once the degradation products of UA expand into the serum, metabolic illnes will worsen the patient’s condition tremendously.
The presented study applies xanthine-inhibitors to reduce UA level. XO-activity was monitored by ESR spectroscopy.
Treatment with either of two XO-inhibitors, decreased waitloss and tissue wasting. Degradation on a cellular level through ROS was lessened by XO-inhibition.